195 related articles for article (PubMed ID: 30876911)
1. IL-33trap is a novel IL-33-neutralizing biologic that inhibits allergic airway inflammation.
Holgado A; Braun H; Van Nuffel E; Detry S; Schuijs MJ; Deswarte K; Vergote K; Haegman M; Baudelet G; Haustraete J; Hammad H; Lambrecht BN; Savvides SN; Afonina IS; Beyaert R
J Allergy Clin Immunol; 2019 Jul; 144(1):204-215. PubMed ID: 30876911
[TBL] [Abstract][Full Text] [Related]
2. Single-Chain Soluble Receptor Fusion Proteins as Versatile Cytokine Inhibitors.
Holgado A; Braun H; Verstraete K; Vanneste D; Callewaert N; Savvides SN; Afonina IS; Beyaert R
Front Immunol; 2020; 11():1422. PubMed ID: 32754154
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory actions of Chemoattractant Receptor-homologous molecule expressed on Th2 by the antagonist MK-7246 in a novel rat model of Alternaria alternata elicited pulmonary inflammation.
Gil MA; Caniga M; Woodhouse JD; Eckman J; Lee HH; Salmon M; Naber J; Hamilton VT; Sevilla RS; Bettano K; Klappenbach J; Moy L; Correll CC; Gervais FG; Siliphaivanh P; Zhang W; Zhang-Hoover J; McLeod RL; Cicmil M
Eur J Pharmacol; 2014 Nov; 743():106-16. PubMed ID: 25261040
[TBL] [Abstract][Full Text] [Related]
4. IL-33 and Its Receptor ST2 after Inhaled Allergen Challenge in Allergic Asthmatics.
Mitchell PD; Salter BM; Oliveria JP; El-Gammal A; Tworek D; Smith SG; Sehmi R; Gauvreau GM; O Apos Byrne PM
Int Arch Allergy Immunol; 2018; 176(2):133-142. PubMed ID: 29694974
[TBL] [Abstract][Full Text] [Related]
5. Cyclic GMP-AMP Triggers Asthma in an IL-33-Dependent Manner That Is Blocked by Amlexanox, a TBK1 Inhibitor.
Ozasa K; Temizoz B; Kusakabe T; Kobari S; Momota M; Coban C; Ito S; Kobiyama K; Kuroda E; Ishii KJ
Front Immunol; 2019; 10():2212. PubMed ID: 31616416
[TBL] [Abstract][Full Text] [Related]
6. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo.
Toki S; Goleniewska K; Reiss S; Zhang J; Bloodworth MH; Stier MT; Zhou W; Newcomb DC; Ware LB; Stanwood GD; Galli A; Boyd KL; Niswender KD; Peebles RS
J Allergy Clin Immunol; 2018 Nov; 142(5):1515-1528.e8. PubMed ID: 29331643
[TBL] [Abstract][Full Text] [Related]
8. Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia.
Boberg E; Johansson K; Malmhäll C; Calvén J; Weidner J; Rådinger M
Front Immunol; 2020; 11():1058. PubMed ID: 32582171
[No Abstract] [Full Text] [Related]
9. Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
Lund SJ; Portillo A; Cavagnero K; Baum RE; Naji LH; Badrani JH; Mehta A; Croft M; Broide DH; Doherty TA
J Immunol; 2017 Aug; 199(3):1096-1104. PubMed ID: 28667163
[TBL] [Abstract][Full Text] [Related]
10. Exogenous interleukin-17A inhibits eosinophil differentiation and alleviates allergic airway inflammation.
Tian BP; Hua W; Xia LX; Jin Y; Lan F; Lee JJ; Lee NA; Li W; Ying SM; Chen ZH; Shen HH
Am J Respir Cell Mol Biol; 2015 Apr; 52(4):459-70. PubMed ID: 25180833
[TBL] [Abstract][Full Text] [Related]
11. Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9
Verma M; Liu S; Michalec L; Sripada A; Gorska MM; Alam R
J Allergy Clin Immunol; 2018 Sep; 142(3):793-803.e8. PubMed ID: 29132961
[TBL] [Abstract][Full Text] [Related]
12. Salidroside suppresses group 2 innate lymphoid cell-mediated allergic airway inflammation by targeting IL-33/ST2 axis.
Cai H; Wang J; Mo Y; Ye L; Zhu G; Song X; Zhu M; Xue X; Yang C; Jin M
Int Immunopharmacol; 2020 Apr; 81():106243. PubMed ID: 32070919
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma.
Kim SH; Hong JH; Lee YC
Eur J Pharmacol; 2013 Feb; 701(1-3):131-43. PubMed ID: 23201068
[TBL] [Abstract][Full Text] [Related]
14. A helminth-derived suppressor of ST2 blocks allergic responses.
Vacca F; Chauché C; Jamwal A; Hinchy EC; Heieis G; Webster H; Ogunkanbi A; Sekne Z; Gregory WF; Wear M; Perona-Wright G; Higgins MK; Nys JA; Cohen ES; McSorley HJ
Elife; 2020 May; 9():. PubMed ID: 32420871
[TBL] [Abstract][Full Text] [Related]
15. Combined blockade of IL-25, IL-33 and TSLP mediates amplified inhibition of airway inflammation and remodelling in a murine model of asthma.
An G; Wang W; Zhang X; Huang Q; Li Q; Chen S; Du X; Corrigan CJ; Huang K; Wang W; Chen Y; Ying S
Respirology; 2020 Jun; 25(6):603-612. PubMed ID: 31610614
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells.
Oczypok EA; Milutinovic PS; Alcorn JF; Khare A; Crum LT; Manni ML; Epperly MW; Pawluk AM; Ray A; Oury TD
J Allergy Clin Immunol; 2015 Sep; 136(3):747-756.e4. PubMed ID: 25930197
[TBL] [Abstract][Full Text] [Related]
17. COX Inhibition Increases
Zhou W; Zhang J; Toki S; Goleniewska K; Norlander AE; Newcomb DC; Wu P; Boyd KL; Kita H; Peebles RS
J Immunol; 2020 Aug; 205(4):1157-1166. PubMed ID: 32690653
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated delivery of soluble ST2 attenuates ovalbumin-induced allergic asthma in mice.
Yin H; Li XY; Liu T; Yuan BH; Zhang BB; Hu SL; Gu HB; Jin XB; Zhu JY
Clin Exp Immunol; 2012 Oct; 170(1):1-9. PubMed ID: 22943195
[TBL] [Abstract][Full Text] [Related]
19. Blockade of IL-33 release and suppression of type 2 innate lymphoid cell responses by helminth secreted products in airway allergy.
McSorley HJ; Blair NF; Smith KA; McKenzie AN; Maizels RM
Mucosal Immunol; 2014 Sep; 7(5):1068-78. PubMed ID: 24496315
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma.
Sun X; Hou T; Cheung E; Iu TN; Tam VW; Chu IM; Tsang MS; Chan PK; Lam CW; Wong CK
Cell Mol Immunol; 2020 Jun; 17(6):631-646. PubMed ID: 31645649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
